内皮角膜移植术后再次角膜移植的风险因素——IRIS登记分析
基于IRIS登记2013至2018年30600例内皮角膜移植术的回顾性队列研究显示,5年再次角膜移植概率为17.4%(95%CI 16.7-18.0)。再次气泡处理(HR 2.24)、既往移植失败(HR 2.07)或大疱性角膜病变(HR 1.47)、后续常规白内障手术(HR 1.61)、青光眼手术及病史、政府保险和黑人种族、吸烟均与再次角膜移植风险升高相关。
要点
- 内皮角膜移植术后5年再次角膜移植概率为17.4%(95%CI 16.7-18.0)。
- 术后再次气泡处理(HR 2.24)和既往移植失败(HR 2.07)是较强的风险因素。
- 黑人种族、政府保险计划和吸烟是再次角膜移植的独立相关因素。
核心结论
- 黑人种族、政府保险计划和吸烟被确定为与再次角膜移植相关的独立因素,此外还包括青光眼病史、青光眼手术以及既往移植失败或大疱性角膜病变作为手术指征。
研究设计与样本
- 回顾性队列研究,纳入IRIS登记(Intelligent Research in Sight)2013至2018年实施的30600例符合纳入标准的内皮角膜移植术,患者年龄18岁及以上。
主要发现
- 5年再次角膜移植概率为17.4%(95%CI 16.7-18.0)。
- 术后再次气泡处理(HR 2.24,95%CI 2.05-2.45)、既往移植失败(HR 2.07,95%CI 1.84-2.32)或大疱性角膜病变(HR 1.47,95%CI 1.33-1.61)相对于Fuchs营养不良作为手术指征,与再次角膜移植风险升高相关。
- 后续常规白内障手术(HR 1.61,95%CI 1.45-1.79)、后续青光眼手术(HR 1.53,95%CI 1.39-1.69)、既往/同期青光眼手术(HR 1.23,95%CI 1.11-1.36)或青光眼病史(HR 1.24,95%CI 1.14-1.35)与再次角膜移植风险升高相关。
- 相对于私人保险,Medicaid(HR 1.47,95%CI 1.13-1.92)、军人/政府保险(HR 1.29,95%CI 1.03-1.60)、Medicare按服务付费(HR 1.17,95%CI 1.05-1.31)或Medicare管理式医疗(HR 1.17,95%CI 1.01-1.36)保险与再次角膜移植风险升高相关。
- 黑人相对于白人种族(HR 1.25,95%CI 1.11-1.40)和吸烟(HR 1.16,95%CI 1.05-1.27)也与再次角膜移植风险升高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess risk factors for repeat keratoplasty after endothelial keratoplasty (EK). DESIGN: Retrospective cohort study. METHODS: EK procedures performed between 2013 and 2018 in the IRIS Registry (Intelligent Research in Sight) were identified. STUDY POPULATION: Patients aged 18 years and older who underwent EK. MAIN OUTCOME MEASURES: (1) Risk factors for repeat keratoplasty and (2) complication rates after EK. A Kaplan-Meier survival analysis was used to determine the probability of repeat keratoplasty. A multivariable shared frailty survival model was used to assess risk factors. RESULTS: A total of 59 344 procedures were identified in the registry, of which 30 600 EK procedures met the inclusion criteria for the analysis. The probability of repeat keratoplasty was 17.4% (95% CI 16.7-18.0) at 5 years. Risk factors for repeat keratoplasty include postoperative rebubbling procedure (HR 2.24, 95% CI 2.05-2.45), prior failed graft (HR 2.07, 95% CI 1.84-2.32) or bullous keratopathy (HR 1.47, 95% CI 1.33-1.61) vs Fuchs dystrophy as surgical indication; subsequent routine cataract surgery (HR 1.61, 95% CI 1.45-1.79), as well as subsequent (HR 1.53, 95% CI 1.39-1.69) and prior/concurrent (HR 1.23, 95% CI 1.11-1.36) glaucoma surgery or history of glaucoma (HR 1.24, 95% CI 1.14-1.35). Medicaid (HR 1.47, 95% CI 1.13-1.92), military/government (HR 1.29, 95% CI 1.03-1.60), Medicare Fee-for-Service (HR 1.17, 95% CI 1.05-1.31) or Medicare Managed (HR 1.17, 95% CI 1.01-1.36) insurances vs private insurance, as well as Black vs White race (HR 1.25, 95% CI 1.11-1.40) and smoking (HR 1.16, 95% CI 1.05-1.27) were also associated with an increased risk of undergoing repeat keratoplasty. CONCLUSIONS: Black race, government-based insurance plans, and smoking were identified as independent factors associated with repeat keratoplasty in addition to history of glaucoma, glaucoma surgery, and prior graft failure or bullous keratopathy as surgical indication.
引用
- Son HS, Lum F, Li C, et al. Risk Factors for Repeat Keratoplasty After Endothelial Keratoplasty-An IRIS Registry Analysis. Am J Ophthalmol. 2022. PMID: 35738395. doi:10.1016/j.ajo.2022.05.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。